Bioactive Compounds
-
B1828 Sarafloxacin HClSummary: Quinolone antibiotic drug -
B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: Competitive eIF4E/eIF4G interaction inhibitor -
B5589 LF 11Summary: displays antimicrobial activity -
C7168 2,6-Dimethoxybenzoic acid -
B6776 LY 215840Summary: 5-HT2/5-HT7 receptor antagonist -
B7558 SR 58611A hydrochlorideSummary: β3-adrenergic receptor agonist -
BA9465 Z-Ala-OMeSummary: An alanine derivative. -
A9947 Cibacron Blue 3G-ASummary: A synthetic dye belonging to the anthraquinone group -
BA4127 CHDI-390576Summary: CHDI-390576, a potent cell-permeable and CNS-permeable class IIa tissue acetylase inhibitor. -
B3310 TerazosinSummary: α1-adrenergic receptor antagonist

